NEW YORK (GenomeWeb) — Rosetta Genomics said today that it is collaborating with the Institute of Molecular Translational Medicine (IMTM) at Palacky University in the Czech Republic to validate and develop a new thyroid cancer diagnostic tool.

Under the agreement, Rosetta and IMTM will work toward improving the diagnosis of malignant tumors in suspected thyroid cancer patients by connecting expertise and clinical samples at IMTM with Rosetta's microRNA platform technology and product development expertise.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.